E&C Lets CMS Exempt Long-Term Care Pharmacies From Lock-In, But Facilities Want More
Long-term care pharmacies are pleased that House Energy & Commerce members opened the door to exempting them from the pharmacy lock-in plan in 21st Century Cures legislation, but they prefer to be excluded outright. The third ‘Cures’ draft, which cleared the health subcommittee Thursday (May 14), includes new language suggesting CMS consider exempting long-term care facility residents from the measure that lets plans limit which pharmacies may dispense drugs prone to abuse, such as pain medicine.
The latest version of the bill also codifies that hospice patients are exempt from the so-called lock-in restrictions and lets CMS exempt other categories of individuals as well.
“The bill can and should be further strengthened by making clear that beneficiaries in skilled nursing facilities and other long-term care settings are exempt by legislation rather than subsequent administrative rule,” said Alan Rosenbloom, president of Senior Care Pharmacy Coalition, which represents independent long-term care pharmacies.
Still, he said the revisions are a “significant step in the right direction” because they recognize some beneficiaries should not be covered by the provision because they already are protected by rules governing the facilities that serve them. Rosenbloom told Inside Health Policy that long-term care pharmacies already are subject to regulations stricter than those that would be applied to so-called safe pharmacy networks.
While the primary goal of the Cures bill is to speed approvals of breakthrough drugs and medical devices, the committee has long been concerned with abuse of prescription drugs and plans to talk with state health officials about the problem next week.
Seniors’ advocates and long-term care pharmacies support drug-abuse prevention, but they worry the pharmacy lock-in measure in the Cure’s legislation would make it difficult for beneficiaries to obtain vital medicine.
The second draft added a beneficiary-appeals measure, but lobbyists for seniors and long-term care pharmacies said that was insufficient. While the third draft went a step further by exempting hospice patients and suggesting CMS consider exempting long-term care facility residents and others, long-term care pharmacies are still worried they could get snagged by the restrictions. — John Wilkerson (jwilkerson@iwpnews.com)
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.